CTRI/2012/01/002347尚未招募4 期
Assessment of the efficacy and safety of the fixed-dose combination of levofloxacin plus cefpodoxime versus levofloxacin, cefpodoxime and amoxicillin/clavulanic acid monotherapy in patients with community acquired pneumonia and acute exacerbation of chronic bronchitis
Dr Sharif Tadvi0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects 18 -65 years age of either sex who are able to give voluntary written informed consent and willing to come for follow up.
- •Patients with clinical signs and symptoms of CAP or AECB as per investigators discretion.
- •Chest X-ray findings suggestive of CAP or AECB
排除标准
- •Subjects requiring hospitalization
- •Subjects with known or suspected hypersensitivity to penicillins, levofloxacin, cefpodoxime or any the constituents of the formulation.
- •Subjects who have received antimicrobial therapy within 7 days prior to enrollment.
- •Patient who severe complications of RTI.
- •An uncontrolled, unstable clinically significant medical condition;
- •Clinically significant abnormal laboratory, vital sign or ECG findings at screening.
- •Pregnant and lactating females.
研究者
相似试验
进行中（未招募）
1 期
Comparison of the efficacy and safety of the fixed-dose combination of xylometazoline and dexpanthenol in SeptaNazal® and xylometazoline in nasal congestion in patients after surgery in the nose and paranasal cavity and in patients with acute rhinitis – SeptaNazal DOUBLE clinical study.EUCTR2015-005155-27-HRKRKA-FARMA d.o.o.223
进行中（未招募）
1 期
Comparison of the efficacy and safety of the fixed-dose combination of xylometazoline and dexpanthenol in SeptaNazal® and xylometazoline in nasal congestion in patients after surgery in the nose and paranasal cavity and in patients with acute rhinitis – SeptaNazal DOUBLE clinical study.asal congestion in patients after nasal surgery or nasal cavities surgery and in patients with acute rhinitisMedDRA version: 19.0Level: HLTClassification code 10028736Term: Nasal congestion and inflammationsSystem Organ Class: 100000004855EUCTR2015-005155-27-SIKrka, d.d., Novo mesto194
招募中
3 期
Evaluation of efficacy and tolerability of a fixed dose combination of Glucosamine sulphate and Omega 3 Fatty Acid For treatment of Painful Osteoarthritis of kneeCTRI/2010/091/000059Merck Limited210
已完成
3 期
A clinical Trial to study the effects of a fixed dose combination of diclofenac and eperisone hydrochloride with plain eperisone hydrochloride in patients with low back paiCTRI/2010/091/002934Eisai Pharmaceuticals India Private Limited, 1st Floor, B-Wing, Marwah Centre, Krishanlal Marwah Marg, Andheri East, Mumbai - 400072240
进行中（未招募）
不适用
Evaluation of the efficacy and safety of unpreserved dexamethasone phosphate 0.1% eye drops (T1910) versus placebo in patients with bilateral treated severe keratoconjunctivitis sicca due to Sjögrens' syndromeMedDRA version: 8.1Level: PTClassification code 10023350Term: Keratoconjunctivitis siccakeratoconjunctivitis siccaEUCTR2006-003391-35-NLaboratoires THEA